HCP Education & Content Development Manager
Revance | |
$85,000-$95,000 annually + annual performance bonus
| |
parental leave, tuition reimbursement, 401(k)
| |
United States, Tennessee | |
May 21, 2026 | |
|
Job Summary: We are seeking a highly motivated and detail-oriented HCP Education & Content Development Manager to lead the development of clinical and educational content for healthcare professionals (HCPs). This role is responsible for creating high-quality, clinically accurate materials that support HCP education across live programs, field training, digital learning platforms, Congresses and Advisory Boards. The ideal candidate has a strong foundation in medical or scientific writing, experience in aesthetics or injectables, and a passion for translating complex clinical concepts into clear, engaging educational experiences. This individual will collaborate cross-functionally with Medical Affairs, Marketing, Clinical Education, and external partners to ensure content is scientifically accurate, compliant, and aligned with brand strategy.
*The final salary offered will depend upon factors that may include but are not limited to the quality and length of experience, education, and geographic location. Responsibilities/Essential Duties: Medical & Educational Content Development
Content Management & Optimization
LMS & Digital Learning Support
Cross-Functional Collaboration
Content Operations & Platform Management
Content Library Management
Field & Faculty Support
Basic Qualifications:
Preferred Qualifications:
Company Summary: Revance is a global company developing, producing, and distributing industry-leading, differentiated products across aesthetics, skincare, and therapeutics. Revance drives innovation beyond convention to offer treatment options for individuals across generations. The Company's vision is to redefine excellence in aesthetics, skincare, and therapeutics through science-powered innovation, with an unwavering commitment to its providers, patients, and consumers. Revance's award-winning products are the result of robust research and development, a cornerstone for the Company, driven by renowned scientists. For more information about Revance, please visit us at www.revance.com. From the first and only peptide-formulated neuromodulator, DAXXIFY (daxibotulinumtoxinA-lanm) for injection; the first facial fillers designed for dynamic movement, the Teoxane RHA Collection of dermal fillers; and our industry-leading microneedling device SkinPen, among others, our award-winning products are one of a kind. RHA technology is proprietary to and manufactured in Switzerland by Teoxane SA, and Revance is an independent distributor of Teoxane SA to supply the Teoxane RHA Collection of dermal fillers to the U.S. market. SkinPen is owned by Crown Laboratories, Inc., a Revance company. What Revance invests in you:
This section of the job description is required by the American with Disability Act (ADA). The ADA requires that job descriptions reflect the physical and mental demands required to effectively perform the essential duties of the job. The ADA prohibits employers from discriminating against a "qualified individual with a disability" in all aspects of the employment relationship. A "qualified individual with a disability" is "an individual who meets the education, experience, skill, and other job-related requirements of a position held or desired, and who, with reasonable accommodation, can perform the essential functions of a specified job." Revance is an Equal Opportunity employer. All qualified applicants will receive consideration for employment based on merit, without regard to race, color, religion, sex, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. | |
$85,000-$95,000 annually + annual performance bonus
parental leave, tuition reimbursement, 401(k)
May 21, 2026